-The Times of India KAITHAL: As politicians and administrators in many northern Indian states were preparing to celebrate Dalit icon B R Ambedkar's 122nd birth anniversary this weekend, more than 100 Dalits were fleeing a small Haryana village after being chased by upper caste goons, angry that a Dalit man had dared to marry one of their girls. Meena and Surya Kant of Pabnama village in Kaithal were in a relationship for...
More »SEARCH RESULT
Total Matching Records found : 3983
The RTI activists' fights -Barkha Mathur
-The Times of India NAGPUR: After voting rights if there has been any other weapon which has empowered an Indian citizen it is the Right to Information (RTI). RTI is used to seek information about matters which affect the aamadami. How much of information is being handed out is still a contentious issue, but the act has definitely created a battalion of social activists. An RTI activist is not exactly the harried...
More »Cottonseed oil rules the kitchens of Gujarat as cheapest cooking oil -Nidhi Nath Srinivas
-The Economic Times The BT cotton revolution, which swept India's countryside, is now doubling up as the source of the country's cheapest cooking oil. And in Narendra Modi's motherland, the Jasubens are loving it. Cottonseed or 'kapasiya' oil is ruling in the kitchens of Gujarat, the largest cotton-growing state. One out of every two bottles of oil consumed in Gujarat contains cottonseed oil. "Earlier, we used around three litres of cottonseed oil...
More »Rajiv assassin’s RTI query: Why my plea was rejected? -Arun Janardhanan
-The Times of India CHENNAI: One of the three convicts on death row for the assassination of Rajiv Gandhi, AG Perarivalan, will on Monday be on a videoconference with Central Information Commissioner Satyananda Mishra on a complaint against Rashtrapati Bhavan and the ministry of home affairs on a petition seeking to know why his mercy plea was rejected in August 2011. A notification on the videoconference was fixed three days ago...
More »Why Novartis case will help innovation-Achal Prabhala and Sudhir Krishnaswamy
-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...
More »
